Recombinant fibroblast growth factor‐18 (sprifermin) enhances microfracture‐induced cartilage healing
Abstract
Posttraumatic osteoarthritis is a disabling condition impacting the mostly young and active population. In the present study, we investigated the impact of intra-articular sprifermin, a recombinant truncated fibroblast growth factor 18, on the outcome of microfracture treatment, a widely used surgical technique to enhance cartilage healing at the site of injury. For this study, we created a cartilage defect and performed microfracture treatment...
Paper Details
Title
Recombinant fibroblast growth factor‐18 (sprifermin) enhances microfracture‐induced cartilage healing
Published Date
May 12, 2021
Volume
40
Issue
3
Pages
553 - 564
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History